Drug

Difluprednate Ophthalmic

26 flagged reaction(s) · 302 total co-reports · max PRR 46.8

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Uveitis	25	46.8	48.3	signal
2	Eye Inflammation	16	42.9	43.7	signal
3	Blindness Unilateral	14	25.1	25.6	signal
4	Intraocular Pressure Increased	11	21.7	21.9	signal
5	Rebound Effect	9	20.1	20.3	signal
6	Eye Pain	40	18.3	19.2	signal
7	Product Availability Issue	15	16.9	17.2	signal
8	Ocular Discomfort	7	16.3	16.4	signal
9	Erythema Multiforme	6	16.3	16.4	signal
10	Photophobia	12	16.2	16.5	signal
11	Blood Lactate Dehydrogenase Increased	10	15.9	16.0	signal
12	Eye Infection	7	15.8	15.9	signal
13	Glaucoma	12	15.7	16.0	signal
14	Adrenal Insufficiency	7	14.8	14.9	signal
15	Eye Irritation	29	13.1	13.6	signal
16	Drug Eruption	9	12.9	13.0	signal
17	Eye Discharge	5	12.4	12.4	signal
18	Ocular Hyperaemia	19	10.3	10.5	signal
19	Paranoia	7	10.2	10.3	signal
20	Inappropriate Antidiuretic Hormone Secretion	4	9.9	10.0	signal
21	Drug Reaction With Eosinophilia And Systemic Symptoms	10	9.9	10.0	signal
22	Device Defective	6	9.4	9.4	signal
23	Blindness	13	8.1	8.2	signal
24	Toxic Skin Eruption	3	7.5	7.5	signal
25	Gastric Cancer	3	3.0	3.0	no signal
26	Device Breakage	3	1.9	1.9	no signal